Adaptimmune Therapeutics
ADAP
#9234
Rank
โ‚น6.24 B
Marketcap
โ‚น23.59
Share price
4.45%
Change (1 day)
-75.41%
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: โ‚น6.24 Billion

As of April 2025 Adaptimmune Therapeutics has a market cap of โ‚น6.24 Billion. This makes Adaptimmune Therapeutics the world's 9234th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น6.24 B-51.74%
2024โ‚น12.95 B-13.62%
2023โ‚น14.99 B-24.25%
2022โ‚น19.79 B-54.6%
2021โ‚น43.59 B-28.55%
2020โ‚น61.01 B578.02%
2019โ‚น8.99 B-78.6%
2018โ‚น42.04 B5.22%
2017โ‚น39.95 B105.12%
2016โ‚น19.48 B-65.66%
2015โ‚น56.73 B

End of Day market cap according to different sources

On Apr 27th, 2025 the market cap of Adaptimmune Therapeutics was reported to be:

โ‚น34.85 Billion
by Nasdaq info icon info icon
โ‚น5.95 Billion
by CompaniesMarketCap info icon info icon
โ‚น5.98 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น97.29 B 1,456.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.39 B-77.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น64.66 B 934.64%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚น901.66 B 14,326.95%๐Ÿ‡บ๐Ÿ‡ธ USA